Die meistzitierten Artikel
|
Rang |
Autoren |
Paper |
Zitierungen |
1 | Motzer, RJ;...; Gauler, TC;...; Sharma, P | Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma NEW ENGL J MED 373(19): 1803-13 (5 NOV 2015) | 2.546 |
2 | Sternberg, CN;...; Kavina, A;...; Hawkins, RE | Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial J CLIN ONCOL 28(6): 1061-8 (20 FEB 2010) | 1.664 |
3 | Esler, MD;...; [+43 Koautoren, darunter 16 aus A, CH, D - z.B. Schmieder, RE; Mahfoud, F; Rump, LC] | Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial LANCET 376(9756): 1903-9 (4 DEC 2010) | 1.461 |
4 | Krum, H;...Sievert, H;...; Esler, M | Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study LANCET 373(9671): 1275-81 (11 APR 2009) | 1.396 |
5 | Baigent, C;...; Wanner, C; Krane, V;...; Collins, R | The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial LANCET 377(9784): 2181-92 (JUN-JUL 2011) | 1.366 |
6 | Ehret, GB;...; [+345 Koautoren, darunter 21 aus D | Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk NATURE 478(7367): 103-9 (6 OCT 2011) | 1.248 |
7 | Wanner, C;...; [+688 Koautoren, darunter 13 aus A, D] | Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes NEW ENGL J MED 375(4): 323-34 (28 JUL 2016) | 1.228 |
8 | Fellstrom, BC;...; Schmieder, RE;...; Mayer, G;...; Wüthrich, RP;...; Zannad, F | Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis NEW ENGL J MED 360(14): 1395-407 (2 APR 2009) | 1.219 |
9 | Pfeffer, MA;...; Eckardt, KU;...; Toto, R | A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease NEW ENGL J MED 361(21): 2019-32 (19 NOV 2009) | 1.218 |
10 | Motzer, RJ;...; Staehler, M;...; Choueiri, TK | Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma NEW ENGL J MED 369(8): 722-31 (22 AUG 2013) | 1.032 |